Metoclopramide Accord

Metoclopramide, the active ingredient in Metoclopramide Accord, is a dopamine antagonist presented as an oral tablet for oral use. It is employed to relieve nausea and vomiting and to promote gastric emptying in adults and pediatric patients when indicated, and is listed in the European Medicines Agency database.

GNH USA supplies Metoclopramide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Metoclopramide is an antiemetic and gastro‑prokinetic used to manage conditions involving nausea, vomiting, and delayed gastric emptying.

- Nausea and vomiting: reduces frequency and severity of symptoms in acute and chronic settings. - Post‑operative nausea and vomiting: helps prevent and treat nausea after surgery. - Chemotherapy‑induced nausea and vomiting: improves control of nausea associated with anticancer drugs. - Gastroparesis: enhances gastric emptying in patients with delayed stomach motility. - Reflux disease: aids in reducing reflux episodes by promoting gastric clearance.

Metoclopramide may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Fatigue: reduced energy levels during daily activities. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Extrapyramidal reactions: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or limb movements. - Neuroleptic malignant syndrome: rare, life‑threatening reaction with fever and muscle rigidity.

Before prescribing Metoclopramide, clinicians should consider several safety factors.

- Assess renal function: adjust use in patients with severe impairment. - Monitor for extrapyramidal symptoms: observe for involuntary movements or rigidity. - Avoid in patients with known hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in pregnancy: evaluate risk‑benefit, especially in the first trimester. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metoclopramide can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): increased risk of extrapyramidal symptoms. - CYP2D6 inhibitors (e.g., fluoxetine): elevated metoclopramide plasma levels. - Monoamine oxidase inhibitors: potential for hypertensive crisis.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedation. - Anticholinergics: may reduce pro‑kinetic effect. - Diabetes medications: possible alteration of glucose control.